Navigation Links
Covance to Present at the Morgan Stanley Global Healthcare Conference
Date:9/7/2012

PRINCETON, N.J., Sept. 7, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 11, 2012 at 9:10 a.m. (ET).  Investors may access a live webcast of the presentation at www.covance.com.  In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $2 billion, global operations in more than 30 countries, and more than 11,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release (and in the webcast announced in this press release), which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue, earnings growth, and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss or delay of large studies, risks associated with acquisitions and investments, the Company's ability to increase order volume, the pace of translation of orders into revenue in late-stage development services, testing mix and geographic mix of kit receipts in central laboratories, fluctuations in currency exchange rates, and other factors described in the Company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no duty to update any forward looking statement to conform the statement to actual results or changes in the Company's expectations.


'/>"/>
SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
2. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
3. Amgen To Present At The Morgan Stanley Global Healthcare Conference
4. Champions Oncology to Present at Rodman & Renshaw Conference
5. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
6. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
7. PDL BioPharma to Present at Upcoming Investor Conferences
8. CVS Caremark to Present at Morgan Stanley Global Healthcare Conference
9. GP Strategies to Present at the BMO Capital Markets 12th Annual Back to School Education Conference
10. Depomed To Present At Morgan Stanley 2012 Healthcare Conference
11. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... , July 14, 2017 Endo International plc (NASDAQ: ... Tuesday, August 8, 2017.  Members of its senior management team will ... open at 8:30 a.m. ET. The dial-in number ... 497-0462, International (678) 509-7598, and the passcode is 45397076. Please dial ... A replay of the call will ...
(Date:7/13/2017)... , July 13, 2017  Centurion Medical Products, a leader in ... DisImpactor ® fecal impaction removal device for hospice patient care. ... Centurion Medical ... Patient pain management and emotional comfort ... can help alleviate patient pain while preventing unneeded emergency department admission ...
(Date:7/13/2017)... ROCKVILLE, Md. , July 13, 2017  New York ... watchers of pharmaceutical markets should be aware of.  From new ... These trends are detailed in a recently completed study, ... following: 1.  Age-Driven ... years, we have been aware of the impact the growing ...
Breaking Medicine Technology:
(Date:7/23/2017)... ... July 23, 2017 , ... Technology is ... and patient-provider relationships. New tools are helping patients become more actively involved in ... Health Care’s Most Wired® survey, released today by the American Hospital Association’s (AHA) ...
(Date:7/23/2017)... ... July 23, 2017 , ... Longtime ... Relief Group – Melbourne, a practice owned by Physician Partners of America at ... management, Dr. Stern also is certified in pediatrics, emergency medicine and anesthesiology. , ...
(Date:7/23/2017)... , ... July 23, 2017 , ... ... announce today the grant of US Patent No. 9,038,640 by the United States ... technology and brings together the combination of Switching, Vacuum, and Cooling mechanisms to ...
(Date:7/22/2017)... CANADA (PRWEB) , ... July 22, 2017 , ... ... place each year with the majority of patients not requiring pain medication after ... Society for Sports Medicine’s Annual Meeting today in Toronto, Ontario, Canada found ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine managing chest ... on the market," said an inventor from Center Valley, Pa. "My idea is to ... , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means ...
Breaking Medicine News(10 mins):